16,547
Views
36
CrossRef citations to date
0
Altmetric
Reviews

Psoriatic arthritis for dermatologists

&
Pages 662-679 | Received 27 Mar 2019, Accepted 28 Mar 2019, Published online: 07 May 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Alice B. Gottlieb & Joseph F. Merola. (2022) A clinical perspective on risk factors and signs of subclinical and early psoriatic arthritis among patients with psoriasis. Journal of Dermatological Treatment 33:4, pages 1907-1915.
Read now
Warren H. Chan, Rohan Singh & Steven R. Feldman. (2021) Should the presence of psoriatic arthritis change how we manage psoriasis?. Journal of Dermatological Treatment 32:8, pages 863-865.
Read now

Articles from other publishers (34)

Hao Trong Nguyen, Anh Tuan Vu, Nhi Thi Uyen Pham, Tu Nguyen Anh Tran, Nguyen Nhat Pham, Huong Thi Thanh Bui, Thuyen Thi Pham, Vi Thi Thuy Dinh, Yen Thi Bui & Thao Thi Phuong Vu. (2023) Comorbidity Burden and Treatment Patterns of Psoriasis in Vietnam: Real-World Data from the EXPAND Study. Dermatology and Therapy 13:12, pages 3193-3208.
Crossref
Ryuichi Ohta & Chiaki Sano. (2023) Challenges in Diagnosing Psoriatic Arthritis in Primary Care: A Meta-Ethnographic Study. Cureus.
Crossref
Supriya Mishra, Lynn Johnson, Laxmi Kaushal & Palak Upadhyay. (2023) Impact of periodontitis on oral health‐related quality of life of patients with psoriatic arthritis. Special Care in Dentistry.
Crossref
Melissa P. Zundell, Michael J. Woodbury, Kathryn Lee, Lourdes M. Perez-Chada, April W. Armstrong, Vibeke Strand, Joseph F. Merola & Alice B. Gottlieb. (2023) Report of the Skin Research Workgroups From the IDEOM Breakout at the GRAPPA 2022 Annual Meeting. The Journal of Rheumatology 50:Suppl 2, pages 47-50.
Crossref
Joseph F. Merola, Dhaval Patil, Antton Egana, Andrea Steffens, Noah S. Webb & Alice B. Gottlieb. (2023) Prevalence of Musculoskeletal Symptoms in Patients with Psoriasis and Predictors Associated with the Development of Psoriatic Arthritis: Retrospective Analysis of a US Claims Database. Dermatology and Therapy 13:11, pages 2635-2648.
Crossref
Joseph F. Merola, Soumya D. Chakravarty, Olivia Choi, Daphne Chan & Alice B. Gottlieb. (2023) A clinical review of structural damage in psoriatic arthritis for dermatologists: From pathogenesis to ongoing controversies. Journal of the American Academy of Dermatology.
Crossref
Natalia Pelet del Toro, Rayan Yahia, Steven R. Feldman, Abby Van Voorhees, Lawrence Green, Sergio Schwartzman, Evan Siegel, Kelly M. Cordoro, Seemal R. Desai, Leon Kircik, Wilson Liao, Jason E. Hawkes, Jeffrey Weinberg, John Koo, Elizabeth Brezinski Wallace, Leah M. Howard, April Armstrong & George Han. (2023) National Psoriasis Foundation Telemedicine Task Force guidance for management of psoriatic disease via telemedicine. JAAD International 12, pages 32-36.
Crossref
Georg Schett, Warner Chen, Sheng Gao, Soumya D. Chakravarty, May Shawi, Frederic Lavie, Miriam Zimmermann, Mohamed Sharaf, Laura C. Coates & Stefan Siebert. (2023) Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study. Arthritis Research & Therapy 25:1.
Crossref
Thomas Bieber. (2023) Disease modification in inflammatory skin disorders: opportunities and challenges. Nature Reviews Drug Discovery 22:8, pages 662-680.
Crossref
Louise H. Hailey, Raj Amarnani, Chris Bundy, Dylan McGagh, Lija James, Shona Kirtley, Denis O'Sullivan, Ingrid Steinkoenig, Rhea Suribhatla, Arani Vivekanantham & Laura C. Coates. (2023) Lifestyle Modifications and Nonpharmacologic Interventions to Improve Outcomes in Psoriatic Arthritis: A Systematic Review. Clinical Therapeutics.
Crossref
Yuanyuan Xu, Linghong Guo, Zhixuan Li, Shuwei Wu & Xian Jiang. (2023) Oral small‐molecule Janus kinase inhibitors and phosphodiesterase 4 inhibitors for psoriatic arthritis: a Bayesian network meta‐analysis. International Journal of Dermatology.
Crossref
Cássio Rafael Moreira, Camila Cataldi de Alcântara, Tamires Flauzino, Ligia Marcia Mario Martin, Marcell Alysson Batisti Lozovoy, Edna Maria Vissoci Reiche & Andréa Name Colado Simão. (2023) IL36G genetic variant is independently associated with susceptibility, severity and joint involvement in psoriasis. Molecular Immunology 159, pages 69-75.
Crossref
April W. Armstrong, Barbra Bohannan, Sicily Mburu, Laura C. Coates, Alexis Ogdie, Ivette Alarcon, Torben Kasparek, Susan Frade, Silvia Fernandez Barrio & Matthias Augustin. (2023) Patient Perspectives on Psoriatic Disease Burden: Results from the Global Psoriasis and Beyond Survey. Dermatology 239:4, pages 621-634.
Crossref
Philippa D. K. Curry, Andrew P. Morris, Anne Barton & James Bluett. (2022) Do genetics contribute to TNF inhibitor response prediction in Psoriatic Arthritis?. The Pharmacogenomics Journal 23:1, pages 1-7.
Crossref
Christine P. Lin, Joseph F. Merola & Elizabeth B. Wallace. (2022) Current and emerging biologic and small molecule systemic treatment options for psoriasis and psoriatic arthritis. Current Opinion in Pharmacology 67, pages 102292.
Crossref
Francesco Cusano, Francesca Sampogna, Alexandra Maria Giovanna Brunasso Vernetti, Stefano Stisi, Gilda Sandri, Giovanna Malara, Luigi Naldi, Michele Pellegrino, Giovanni Luigi Tripepi, Umberto Di Luzio Paparatti, Concetto Paolo Agnusdei, Claudio Bonifati, Antonella Celano, Valeria Corazza, Federica D'Agostino, Rocco De Pasquale, Emilio Filippucci, Rosario Foti, Giovanna Galdo, Fabiana Gai, Giulia Ganzetti, Dario Graceffa, Mara Maccarone, Annamaria Mazzotta, Gennaro Melchionda, Francesca Molinaro, Franco Paoletti, Silvia Tonolo, Adriano Vercellone, Rosetta Vitetta, Cesare Massone & Gian Domenico Sebastiani. (2022) A consensus-based approach on the management of patients with both psoriasis and psoriatic arthritis in the dermatological and rheumatological settings in Italy: The ADOI PSO-Amore Project. Dermatology Reports 14:3.
Crossref
Philip J. Mease, Dafna D. Gladman, Joseph F. Merola, Atul Deodhar, Alexis Ogdie, David H. Collier, Lyrica Liu & Arthur Kavanaugh. (2022) Potential Impact of Sex and BMI on Response to Therapy in Psoriatic Arthritis: Post Hoc Analysis of Results From the SEAM-PsA Trial. The Journal of Rheumatology 49:8, pages 885-893.
Crossref
Philip J Mease, Atul A Deodhar, Désirée van der Heijde, Frank Behrens, Alan J Kivitz, Jeffrey Neal, Jonghyeon Kim, Shalabh Singhal, Miroslawa Nowak & Subhashis Banerjee. (2022) Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis. Annals of the Rheumatic Diseases 81:6, pages 815-822.
Crossref
Alice B. Gottlieb, Alvin F. Wells & Joseph F. Merola. (2022) Telemedicine and psoriatic arthritis: best practices and considerations for dermatologists and rheumatologists. Clinical Rheumatology 41:5, pages 1271-1283.
Crossref
Paolo Gisondi, Davide Geat, Martina Maurelli, Luca Degli Esposti, Francesco Bellinato & Giampiero Girolomoni. (2022) Cost per Responder Analysis of Secukinumab versus Adalimumab in the Treatment of Psoriatic Disease. Vaccines 10:5, pages 646.
Crossref
Zhoulan Zheng, Qianyu Guo, Dan Ma, Xuexue Wang, Chengqiang Zhang, Haiyao Wang, Liyun Zhang & Gailian Zhang. (2022) Related Risk Factors and Treatment Management of Psoriatic Arthritis Complicated With Cardiovascular Disease. Frontiers in Cardiovascular Medicine 9.
Crossref
Cacilda da Silva Souza, Cláudia Goldenstein-Schainberg, Sonia Maria Alvarenga Anti Loduca Lima, Natali Spelling Gormezano, Renata Ferreira Magalhães & Roberto Ranza. (2022) Clinical Specialty Setting as Determinant of Management of Psoriatic Arthritis. JCR: Journal of Clinical Rheumatology 28:3, pages 120-125.
Crossref
Nan Wang, Linjiao Yang, Lili Shang, Zhaojun Liang, Yanlin Wang, Min Feng, Shuting Yu, Xiaoying Li, Chong Gao, Zhenyu Li & Jing Luo. (2022) Altered Fecal Metabolomics and Potential Biomarkers of Psoriatic Arthritis Differing From Rheumatoid Arthritis. Frontiers in Immunology 13.
Crossref
Fernando Valenzuela & Rodrigo Flores. 2022. Textbook of Dermatologic Ultrasound. Textbook of Dermatologic Ultrasound 345 365 .
Iris Jazmin Colunga-Pedraza, Dionicio Angel Galarza-Delgado, Jose Ramon Azpiri-Lopez, Alejandra Berenice Rodriguez-Romero, Natalia Guajardo-Jauregui, Jesus Alberto Cardenas-de la Garza, Salvador Lugo-Perez, Alejandro Meza-Garza, Julieta Loya-Acosta & Andrea Cecilia Garza-Acosta. (2021) Nail involvement in psoriatic arthritis patients is an independent risk factor for carotid plaque. Annals of the Rheumatic Diseases 80:12, pages 1629-1631.
Crossref
William Saalfeld, Amanda M. Mixon, Jonna Zelie & Eileen J. Lydon. (2021) Differentiating Psoriatic Arthritis from Osteoarthritis and Rheumatoid Arthritis: A Narrative Review and Guide for Advanced Practice Providers. Rheumatology and Therapy 8:4, pages 1493-1517.
Crossref
Matteo Megna, Sonia Sofia Ocampo-Garza, Luca Potestio, Giuseppina Fontanella, Lucia Gallo, Sara Cacciapuoti, Angelo Ruggiero & Gabriella Fabbrocini. (2021) New-Onset Psoriatic Arthritis under Biologics in Psoriasis Patients: An Increasing Challenge?. Biomedicines 9:10, pages 1482.
Crossref
Denis Poddubnyy, Deepak R. Jadon, Filip Van den Bosch, Philip J. Mease & Dafna D. Gladman. (2021) Axial involvement in psoriatic arthritis: An update for rheumatologists. Seminars in Arthritis and Rheumatism 51:4, pages 880-887.
Crossref
Achala Liyanage, S. Verni, G. Liyanage, V. De Silva, J. Akarawita, C. Gunasekera, J. Rubasinghe, S. Imafuku & S. Lekamwasam. (2021) Validation of Sinhala version of Psoriasis Epidemiology Screening Tool. Clinical Rheumatology 40:8, pages 3127-3134.
Crossref
A. Blauvelt, C. Leonardi, B. Elewski, J.J. Crowley, L.C. Guenther, M. Gooderham, R.G. Langley, R. Vender, A. Pinter, C.E.M. Griffiths, Y. Tada, H. Elmaraghy, R.G. Lima, G. Gallo, L. Renda, R. Burge, S.Y. Park, B. Zhu & K. Papp. (2020) A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded trial*. British Journal of Dermatology 184:6, pages 1047-1058.
Crossref
Rafaela Silva Guimaraes Gonçalves, Georgia Alves Pereira, Emerson de Andrade Lima, Thiago Henrique Fernandes Martins, José Otamir Andrade Junior, Jonas Braynner Carvalho, Henrique Ataíde Mariz, Andrea Tavares Dantas & Angela Luzia Branco Pinto Duarte. (2020) Validation of the Toronto Psoriatic Arthritis Screen II (ToPAS II) questionnaire in a Brazilian population. Clinical Rheumatology 40:5, pages 1889-1892.
Crossref
Tiago Torres, Anabela Barcelos, Paulo Filipe & João Eurico Fonseca. (2021) A Systematic Review With Network Meta-Analysis of the Available Biologic Therapies for Psoriatic Disease Domains. Frontiers in Medicine 7.
Crossref
Philip J Mease, Proton Rahman, Alice B Gottlieb, Alexa P Kollmeier, Elizabeth C Hsia, Xie L Xu, Shihong Sheng, Prasheen Agarwal, Bei Zhou, Yanli Zhuang, Désirée van der Heijde & Iain B McInnes. (2020) Guselkumab in biologic-naive patients with active psoriatic arthritis (DISCOVER-2): a double-blind, randomised, placebo-controlled phase 3 trial. The Lancet 395:10230, pages 1126-1136.
Crossref
Rema Bishara Garzuzi, Tal Gazitt, Muna Elias & Devy Zisman. 2020. Rheumatic Disease in Geriatrics. Rheumatic Disease in Geriatrics 293 310 .